E.g., 03/28/2024
E.g., 03/28/2024

Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index® Molecular Oncology Test Presented at ASCO 2010 Annual Meeting*

06 June, 2010

bioTheranostics, a bioMérieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company’s CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.

bioMérieux Showcases Myla® at ASM 2010: New Informatics Solution to Transform the Microbiology Laboratory

25 May, 2010

Innovative solution optimizes laboratory workflow and clinical information management

bioMérieux Extends Portfolio of Full Micriobiology Lab Automation solutions at ASM General Meeting

24 May, 2010

bioMérieux, a world leader in the field of in vitro diagnostics, today announced that it will present an expanded portfolio of microbiology laboratory automation solutions during the 110th General Meeting of the American Society for Microbiology (ASM) in San Diego, Calif.

bioMérieux Presents 2010 Sonnenwirth Award for Leadership in Clinical Microbiology to Patricia Charache

24 May, 2010

Charache to Give Accompanying Lecture during the American Society for Microbiology General Meeting on May 24th in San Diego

Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Micriobiology

21 May, 2010

Shimadzu and bioMérieux announce today that they have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology laboratories.

bioMérieux Co-Sponsors French Medical Days in Shanghai

17 May, 2010

bioMérieux plays a driving role in Sino-French healthcare cooperation: · Organization of seminar on emergency medicine · Inauguration of Sino-French Emergency Satellite Lab at Xinhua Hospital · Renewal and extension of the partnership with Fudan University Shanghai Cancer Hospital · Pilot project with the Shanghai Health Bureau on decentralized diagnostics in Community and County Healthcare Centers (CHC)

bioMérieux Strengthens North American Executive Management Team

17 May, 2010

Manuel Mendez to serve as Executive Vice President, Commercial Operations for bioMérieux Inc.

bioMérieux and GlaxoSmithKline Enter into Alliance to Develop Molecular Theranostic Test for Cancer Treatment Selection

10 May, 2010

bioMérieux and GlaxoSmithKline (GSK) have signed an agreement to develop a novel molecular test for cancer. In this new collaboration, the two companies will develop a theranostic test to aid oncologists in choosing the appropriate treatment for metastatic melanoma (skin cancer).

bioMérieux and Knome Sign Strategic Partnership

21 April, 2010

Exclusive agreement to bring state-of-the-art genome sequencing technology to the in vitro diagnostics market. bioMérieux takes equity stake in Knome.

bioMérieux - First Quarter 2010 Business Review

21 April, 2010

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2010.

Pioneering Diagnostics